APA Alıntı

Choueiri, T. K., Xie, W., D’Amico, A. V., Ross, R. W., Hu, J. C., Pomerantz, M., . . . Oh, W. K. (2009). Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy.

Chicago Stili Alıntı

Choueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.

MLA Alıntı

Choueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.